BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 33568541)

  • 1. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
    Solé G; Mathis S; Friedman D; Salort-Campana E; Tard C; Bouhour F; Magot A; Annane D; Clair B; Le Masson G; Soulages A; Duval F; Carla L; Violleau MH; Saulnier T; Segovia-Kueny S; Kern L; Antoine JC; Beaudonnet G; Audic F; Kremer L; Chanson JB; Nadaj-Pakleza A; Stojkovic T; Cintas P; Spinazzi M; Foubert-Samier A; Attarian S
    Neurology; 2021 Apr; 96(16):e2109-e2120. PubMed ID: 33568541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
    Louapre C; Collongues N; Stankoff B; Giannesini C; Papeix C; Bensa C; Deschamps R; Créange A; Wahab A; Pelletier J; Heinzlef O; Labauge P; Guilloton L; Ahle G; Goudot M; Bigaut K; Laplaud DA; Vukusic S; Lubetzki C; De Sèze J; ; Derouiche F; Tourbah A; Mathey G; Théaudin M; Sellal F; Dugay MH; Zéphir H; Vermersch P; Durand-Dubief F; Françoise R; Androdias-Condemine G; Pique J; Codjia P; Tilikete C; Marcaud V; Lebrun-Frenay C; Cohen M; Ungureanu A; Maillart E; Beigneux Y; Roux T; Corvol JC; Bordet A; Mathieu Y; Le Breton F; Boulos DD; Gout O; Guéguen A; Moulignier A; Boudot M; Chardain A; Coulette S; Manchon E; Ayache SS; Moreau T; Garcia PY; Kumaran D; Castelnovo G; Thouvenot E; Taithe F; Poupart J; Kwiatkowski A; Defer G; Derache N; Branger P; Biotti D; Ciron J; Clerc C; Vaillant M; Magy L; Montcuquet A; Kerschen P; Coustans M; Guennoc AM; Brochet B; Ouallet JC; Ruet A; Dulau C; Wiertlewski S; Berger E; Buch D; Bourre B; Pallix-Guiot M; Maurousset A; Audoin B; Rico A; Maarouf A; Edan G; Papassin J; Videt D
    JAMA Neurol; 2020 Sep; 77(9):1079-1088. PubMed ID: 32589189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis and COVID-19: A case series and comparison with literature.
    Saied Z; Rachdi A; Thamlaoui S; Nabli F; Jeridi C; Baffoun N; Kaddour C; Belal S; Ben Sassi S
    Acta Neurol Scand; 2021 Sep; 144(3):334-340. PubMed ID: 33914898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
    Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
    Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
    Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
    Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
    Stascheit F; Grittner U; Hoffmann S; Mergenthaler P; Schroeter M; Ruck T; Pawlitzki M; Blaes F; Kaiser J; Schara U; Della-Marina A; Thieme A; Hagenacker T; Jacobi C; Berger B; Urban PP; Knop KC; Schalke B; Lee DH; Kalischewski P; Wiendl H; Meisel A
    J Neurol; 2023 Jan; 270(1):1-12. PubMed ID: 36166068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.
    Businaro P; Vaghi G; Marchioni E; Diamanti L; Arceri S; Bini P; Colombo E; Cosentino G; Alfonsi E; Costa A; Ravaglia S; Mallucci G; Ballante E; Franciotta D; Gastaldi M
    Muscle Nerve; 2021 Aug; 64(2):206-211. PubMed ID: 34031902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study.
    Barnay M; Duval F; Solé G; Carla L; Mathis S; Le Masson G
    J Neurol; 2022 Dec; 269(12):6572-6581. PubMed ID: 35995991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 infection in myasthenia gravis: Clinical course and outcomes.
    Thomas EV; Bou G; Barton S; Hutto S; Garcia-Santibanez R
    Muscle Nerve; 2023 Aug; 68(2):171-175. PubMed ID: 37326164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravis.
    Li Y; Emmett CD; Cobbaert M; Sanders DB; Juel VC; Hobson-Webb LD; Massey JM; Gable KL; Raja SM; Gonzalez NL; Guptill JT
    Muscle Nerve; 2021 Mar; 63(3):357-364. PubMed ID: 33280141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study.
    Rzepiński Ł; Zawadka-Kunikowska M
    Neurol Neurochir Pol; 2022; 56(1):61-67. PubMed ID: 34346049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
    Solé G; Salort-Campana E; Pereon Y; Stojkovic T; Wahbi K; Cintas P; Adams D; Laforet P; Tiffreau V; Desguerre I; Pisella LI; Molon A; Attarian S;
    Rev Neurol (Paris); 2020 Jun; 176(6):507-515. PubMed ID: 32354651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review.
    Sriwastava S; Tandon M; Kataria S; Daimee M; Sultan S
    J Neurol; 2021 Aug; 268(8):2690-2696. PubMed ID: 33047223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19.
    Scopelliti G; Osio M; Arquati M; Pantoni L
    Neurol Sci; 2020 Dec; 41(12):3419-3421. PubMed ID: 33068195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis.
    Scarsi E; Massucco S; Ferraro PM; Cella A; Grisanti SG; Assini A; Beronio A; Della Cava F; Gemelli C; Bandini F; Serrati C; Del Sette M; Schenone A; Benedetti L; Prada V; Grandis M
    Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
    Garassino MC; Whisenant JG; Huang LC; Trama A; Torri V; Agustoni F; Baena J; Banna G; Berardi R; Bettini AC; Bria E; Brighenti M; Cadranel J; De Toma A; Chini C; Cortellini A; Felip E; Finocchiaro G; Garrido P; Genova C; Giusti R; Gregorc V; Grossi F; Grosso F; Intagliata S; La Verde N; Liu SV; Mazieres J; Mercadante E; Michielin O; Minuti G; Moro-Sibilot D; Pasello G; Passaro A; Scotti V; Solli P; Stroppa E; Tiseo M; Viscardi G; Voltolini L; Wu YL; Zai S; Pancaldi V; Dingemans AM; Van Meerbeeck J; Barlesi F; Wakelee H; Peters S; Horn L;
    Lancet Oncol; 2020 Jul; 21(7):914-922. PubMed ID: 32539942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
    Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
    Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatedly negative PCR results in patients with COVID-19 symptoms: Do they have SARS-CoV-2 infection or not?
    Beneš J; Džupová O; Poláková A; Sojková N
    Epidemiol Mikrobiol Imunol; 2021; 70(1):3-9. PubMed ID: 33853332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
    Lièvre A; Turpin A; Ray-Coquard I; Le Malicot K; Thariat J; Ahle G; Neuzillet C; Paoletti X; Bouché O; Aldabbagh K; Michel P; Debieuvre D; Canellas A; Wislez M; Laurent L; Mabro M; Colle R; Hardy-Bessard AC; Mansi L; Colomba E; Bourhis J; Gorphe P; Pointreau Y; Idbaih A; Ursu R; Di Stefano AL; Zalcman G; Aparicio T;
    Eur J Cancer; 2020 Dec; 141():62-81. PubMed ID: 33129039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.